Institutional review of compliance with NCCN guidelines for breast cancer: Lessons learned from real-time multidimensional synoptic reporting

Titilayo O. Adegboyega, Jeffrey Landercasper, Jared H. Linebarger, Jeanne M. Johnson, Jeremiah J. Andersen, Leah L. Dietrich, Collin D. Driscoll, Meghana Raghavendra, Anusha R. Madadi, Mohammed Al-Hamadani, Choua A. Vang, Kristen A. Marcou, Jane Hudak, Ronald S. Go

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Variations exist in compliance with NCCN Guidelines. Prior reports of adherence to NCCN Guidelines contain limitations because of lack of contemporary review and incomplete listing of reasons for noncompliance. Purpose: To assess institutional compliance and assist national quality improvement strategies through identifying valid reasons for noncompliance. Methods: Compliance with NCCN Guidelines was recorded prospectively using electronic synoptic templates for patients with newly diagnosed breast cancer treated at a single institution between January 2010 and December 2011. Compliance with NCCN Guidelines was recorded. The accuracy of real-time synoptic auditing methods compared with retrospective chart review and reasons for noncompliance was assessed. SAS 9.3 software was used for data analysis. Results: Compliance with NCCN Guidelines among 395 patients was 94% for initial staging evaluation, 97% for surgery, 91% for chemotherapy, 89% for hormone therapy, 91% for radiation therapy, 85% for follow-up, and 100% for determination of estrogen receptor/progesterone receptor and HER2 status. Age, comorbidities, and stage influenced guideline compliance. The most common reasons for noncompliance were patient refusal, patient choice after shared decision-making, and overuse of testing. Synoptic templated reporting was accurate in 97% patients. Conclusions: High compliance with NCCN Guidelines was demonstrated. Reasons for noncompliance were identifiable. Compliance and nonadherence can be evaluated quickly with electronic synoptic reporting. This allows real-time action plans to address quality concerns and aids national risk adjustment for comparison and benchmarking.

Original languageEnglish (US)
Pages (from-to)177-183
Number of pages7
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number2
StatePublished - Feb 1 2015

Fingerprint

Guidelines
Breast Neoplasms
Compliance
Risk Adjustment
Benchmarking
Progesterone Receptors
Patient Compliance
Quality Improvement
Estrogen Receptors
Comorbidity
Decision Making
Radiotherapy
Software
Hormones
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Adegboyega, T. O., Landercasper, J., Linebarger, J. H., Johnson, J. M., Andersen, J. J., Dietrich, L. L., ... Go, R. S. (2015). Institutional review of compliance with NCCN guidelines for breast cancer: Lessons learned from real-time multidimensional synoptic reporting. JNCCN Journal of the National Comprehensive Cancer Network, 13(2), 177-183.

Institutional review of compliance with NCCN guidelines for breast cancer : Lessons learned from real-time multidimensional synoptic reporting. / Adegboyega, Titilayo O.; Landercasper, Jeffrey; Linebarger, Jared H.; Johnson, Jeanne M.; Andersen, Jeremiah J.; Dietrich, Leah L.; Driscoll, Collin D.; Raghavendra, Meghana; Madadi, Anusha R.; Al-Hamadani, Mohammed; Vang, Choua A.; Marcou, Kristen A.; Hudak, Jane; Go, Ronald S.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 13, No. 2, 01.02.2015, p. 177-183.

Research output: Contribution to journalArticle

Adegboyega, TO, Landercasper, J, Linebarger, JH, Johnson, JM, Andersen, JJ, Dietrich, LL, Driscoll, CD, Raghavendra, M, Madadi, AR, Al-Hamadani, M, Vang, CA, Marcou, KA, Hudak, J & Go, RS 2015, 'Institutional review of compliance with NCCN guidelines for breast cancer: Lessons learned from real-time multidimensional synoptic reporting', JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 2, pp. 177-183.
Adegboyega, Titilayo O. ; Landercasper, Jeffrey ; Linebarger, Jared H. ; Johnson, Jeanne M. ; Andersen, Jeremiah J. ; Dietrich, Leah L. ; Driscoll, Collin D. ; Raghavendra, Meghana ; Madadi, Anusha R. ; Al-Hamadani, Mohammed ; Vang, Choua A. ; Marcou, Kristen A. ; Hudak, Jane ; Go, Ronald S. / Institutional review of compliance with NCCN guidelines for breast cancer : Lessons learned from real-time multidimensional synoptic reporting. In: JNCCN Journal of the National Comprehensive Cancer Network. 2015 ; Vol. 13, No. 2. pp. 177-183.
@article{6416bee499d147008c42ab00ba895ffa,
title = "Institutional review of compliance with NCCN guidelines for breast cancer: Lessons learned from real-time multidimensional synoptic reporting",
abstract = "Background: Variations exist in compliance with NCCN Guidelines. Prior reports of adherence to NCCN Guidelines contain limitations because of lack of contemporary review and incomplete listing of reasons for noncompliance. Purpose: To assess institutional compliance and assist national quality improvement strategies through identifying valid reasons for noncompliance. Methods: Compliance with NCCN Guidelines was recorded prospectively using electronic synoptic templates for patients with newly diagnosed breast cancer treated at a single institution between January 2010 and December 2011. Compliance with NCCN Guidelines was recorded. The accuracy of real-time synoptic auditing methods compared with retrospective chart review and reasons for noncompliance was assessed. SAS 9.3 software was used for data analysis. Results: Compliance with NCCN Guidelines among 395 patients was 94{\%} for initial staging evaluation, 97{\%} for surgery, 91{\%} for chemotherapy, 89{\%} for hormone therapy, 91{\%} for radiation therapy, 85{\%} for follow-up, and 100{\%} for determination of estrogen receptor/progesterone receptor and HER2 status. Age, comorbidities, and stage influenced guideline compliance. The most common reasons for noncompliance were patient refusal, patient choice after shared decision-making, and overuse of testing. Synoptic templated reporting was accurate in 97{\%} patients. Conclusions: High compliance with NCCN Guidelines was demonstrated. Reasons for noncompliance were identifiable. Compliance and nonadherence can be evaluated quickly with electronic synoptic reporting. This allows real-time action plans to address quality concerns and aids national risk adjustment for comparison and benchmarking.",
author = "Adegboyega, {Titilayo O.} and Jeffrey Landercasper and Linebarger, {Jared H.} and Johnson, {Jeanne M.} and Andersen, {Jeremiah J.} and Dietrich, {Leah L.} and Driscoll, {Collin D.} and Meghana Raghavendra and Madadi, {Anusha R.} and Mohammed Al-Hamadani and Vang, {Choua A.} and Marcou, {Kristen A.} and Jane Hudak and Go, {Ronald S.}",
year = "2015",
month = "2",
day = "1",
language = "English (US)",
volume = "13",
pages = "177--183",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "2",

}

TY - JOUR

T1 - Institutional review of compliance with NCCN guidelines for breast cancer

T2 - Lessons learned from real-time multidimensional synoptic reporting

AU - Adegboyega, Titilayo O.

AU - Landercasper, Jeffrey

AU - Linebarger, Jared H.

AU - Johnson, Jeanne M.

AU - Andersen, Jeremiah J.

AU - Dietrich, Leah L.

AU - Driscoll, Collin D.

AU - Raghavendra, Meghana

AU - Madadi, Anusha R.

AU - Al-Hamadani, Mohammed

AU - Vang, Choua A.

AU - Marcou, Kristen A.

AU - Hudak, Jane

AU - Go, Ronald S.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Background: Variations exist in compliance with NCCN Guidelines. Prior reports of adherence to NCCN Guidelines contain limitations because of lack of contemporary review and incomplete listing of reasons for noncompliance. Purpose: To assess institutional compliance and assist national quality improvement strategies through identifying valid reasons for noncompliance. Methods: Compliance with NCCN Guidelines was recorded prospectively using electronic synoptic templates for patients with newly diagnosed breast cancer treated at a single institution between January 2010 and December 2011. Compliance with NCCN Guidelines was recorded. The accuracy of real-time synoptic auditing methods compared with retrospective chart review and reasons for noncompliance was assessed. SAS 9.3 software was used for data analysis. Results: Compliance with NCCN Guidelines among 395 patients was 94% for initial staging evaluation, 97% for surgery, 91% for chemotherapy, 89% for hormone therapy, 91% for radiation therapy, 85% for follow-up, and 100% for determination of estrogen receptor/progesterone receptor and HER2 status. Age, comorbidities, and stage influenced guideline compliance. The most common reasons for noncompliance were patient refusal, patient choice after shared decision-making, and overuse of testing. Synoptic templated reporting was accurate in 97% patients. Conclusions: High compliance with NCCN Guidelines was demonstrated. Reasons for noncompliance were identifiable. Compliance and nonadherence can be evaluated quickly with electronic synoptic reporting. This allows real-time action plans to address quality concerns and aids national risk adjustment for comparison and benchmarking.

AB - Background: Variations exist in compliance with NCCN Guidelines. Prior reports of adherence to NCCN Guidelines contain limitations because of lack of contemporary review and incomplete listing of reasons for noncompliance. Purpose: To assess institutional compliance and assist national quality improvement strategies through identifying valid reasons for noncompliance. Methods: Compliance with NCCN Guidelines was recorded prospectively using electronic synoptic templates for patients with newly diagnosed breast cancer treated at a single institution between January 2010 and December 2011. Compliance with NCCN Guidelines was recorded. The accuracy of real-time synoptic auditing methods compared with retrospective chart review and reasons for noncompliance was assessed. SAS 9.3 software was used for data analysis. Results: Compliance with NCCN Guidelines among 395 patients was 94% for initial staging evaluation, 97% for surgery, 91% for chemotherapy, 89% for hormone therapy, 91% for radiation therapy, 85% for follow-up, and 100% for determination of estrogen receptor/progesterone receptor and HER2 status. Age, comorbidities, and stage influenced guideline compliance. The most common reasons for noncompliance were patient refusal, patient choice after shared decision-making, and overuse of testing. Synoptic templated reporting was accurate in 97% patients. Conclusions: High compliance with NCCN Guidelines was demonstrated. Reasons for noncompliance were identifiable. Compliance and nonadherence can be evaluated quickly with electronic synoptic reporting. This allows real-time action plans to address quality concerns and aids national risk adjustment for comparison and benchmarking.

UR - http://www.scopus.com/inward/record.url?scp=84923507767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923507767&partnerID=8YFLogxK

M3 - Article

C2 - 25691610

AN - SCOPUS:84923507767

VL - 13

SP - 177

EP - 183

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 2

ER -